Contact

1. Introduction

COVID-19, a novel pathogenic coronavirus (2019-nCoV or SARS-CoV2) induced disease, emerged in China and spread globally rapidly.

GeneMedi produces kinds of recombinant 2019 nCoV(SARS2 coronavirus) antigens as shown below: Nucleocapsid(N protein), Spike(S protein), RBD, S1+S2 ECD, Envelope (E protein), 3C-like Proteinase. All the recombinant proteins of 2019 nCoV are suitable for in functional ELISA,lateral-flow tests, and other immunoassays.

GeneMedi has submitted a preprints review about COVID-19 and 2019-nCoV.

Click here for the full-text reading:
Viral vector-based vaccine; DNA-based vaccine; RNA based vaccine - A landscape for vaccine technology against infectious disease, COVID-19 and tumor.

An Insight of comparison between COVID-19 (2019-nCoV disease) and SARS in pathology and pathogenesis

Landscape Coronavirus Disease 2019 test (COVID-19 test) in vitro -- A comparison of PCR vs Immunoassay vs Crispr-Based test

In the mission of helping global scientists for the development of diagnosis and drug against 2019 nCoV(SARS2 coronavirus), GeneMedi scientists will keep moving.



2. Protocol & primers $ probes collection for Real-time (rRT-PCR) Panel based COVID-19 (2019 nCoV, SARS2 coronavirus) detection.


PDF file download:

  • pdf download2019 nCoV peiris-detection protocol-16-1-20-HKU
  • pdf download2019-Novel Coronavirus (2019-nCoV) Real-time rRT-PCR Panel Primers and Probes-USCDC
  • pdf downloadChina CDC 2019-nCoV detection primer
  • pdf downloadConstruction_of_Lentivirus-Based_Reference_Materia
  • pdf downloadDiagnostic detection of Wuhan coronavirus 2019 by real-time RT-PCR – Charité, Berlin Germany
  • pdf downloaduscdcrt-pcr-panel-primer-probes


  • 3. A landscape and collection for Drug discovery of COVID-19 (2019 nCoV, SARS2 coronavirus)


    1) Top 35 Treatments in Development against COVID-19

    2) Therapeutic options for the 2019 novel coronavirus (2019-nCoV)-supplementary table

    PDF file download:

  • pdf downloadTherapeutic options for the 2019 novel coronavirus (2019-nCoV)
  • pdf downloadTherapeutic options for the 2019 novel coronavirus (2019-nCoV)-supplementary table


  • 4. Landscape of vaccine development against COVID-19 (2019 nCoV, SARS2 coronavirus).


    Landscape and collection of vaccine development against COVID-19 (2019 nCoV, SARS2 coronavirus)

    5. Research Guidance of COVID-19 (2019 nCoV, SARS2 coronavirus).


  • pdf download20200114-interim-laboratory-guidance-version
  • pdf downloadA cooodinated global research roadmap-WHO


  • Other knowledge bases

    AAV Knowledge Basepdf download
    CRISPR/Cas9-gRNA system Knowledge Base
    Adenovirus Knowledge Basepdf download
    Transfection Knowledge Base
    Lentivirus Knowledge Basepdf download
    Advanced cell therapy




    GENEMEDI
    6th Floor, Buiding No.2, Kangxin Road 3377, Shanghai, China
    Email: [email protected] [email protected]
    Telephone: +86-21-50478399   Fax: 86-21-50478399
    Privacy Policy
    Chinese Website

    COVID-19
    related
    protocols,
    data and
    products

    COVID-19 related protocols, data and products

    ×